An Italian company evaluates and develops nutraceuticals, cosmeceuticals and healthy food products based on Italian extra virgin organic olive oil and on its related polyphenols content.
The company developed a patent protected blend of hydroxytyrosol plus vitamin E, clinically proven to reduce fatty liver damage. Increased levels of obesity are driving an epidemic of non-alcoholic fatty liver disease (NAFLD). The Italian company provides a clinically proven combination of two natural constituents that can be easily integrated into the diet to reduce NAFLD-related liver damage in adults and children. The company offers a food supplement (capsules) formulated on hydroxytyrosol from olive extract from Italian extra virgin organic olive oil, also providing other polyphenols with strong antioxidant and anti-inflammatory properties.
Hydroxytyrosol has the effect of controlling cholesterol and plasma triglycerides and many inflammatory diseases of the skin and mucous membranes related to oxidative stress (i.e atopic dermatitis, psoriasis, eczema).
The company is now willing to expand internationally offering its innovative product and is looking for new distribution channels in Germany, France, Netherlands, Spain and Sweden. The Italian company has already started a collaboration for the distribution of the product in the UK.